Clinical Trial Update: An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis [Phase 3]

View source ↗

Summary

A Phase 3 induction trial is evaluating the efficacy and safety of Duvakitug in participants with moderately to severely active ulcerative colitis and is curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Duvakitug

Snippet

Sponsor: Sanofi | Conditions: Ulcerative Colitis | Phase 3 | Status: RECRUITING